lentinan has been researched along with Neoplasm Metastasis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Li, M; Li, WW; Liu, HJ; Liu, YR; Qin, Y; Sheng, PZ; Sun, B; Sun, T; Tian, YX; Wang, LM; Yang, C; Zhou, HG; Zhu, GH; Zong, SM | 1 |
Hamuro, J; Kikuchi, T; Suga, T; Suzuki, M; Takatsuki, F | 1 |
Higashi, Y; Nakagomi, K; Negishi, T; Oowada, F; Ozawa, K; Saito, H; Satake, I; Tari, K; Yamada, T; Yoshida, K | 1 |
Ladányi, A; Lapis, K; Tímár, J | 1 |
Ladányi, A; Lapis, K; Paku, S; Pápay, J; Szende, B; Timár, J | 1 |
Chihara, G; Hamuro, J; Maeda, YY; Sasaki, T; Shiio, T; Suga, T; Takasuka, N | 1 |
Chihara, G | 1 |
1 review(s) available for lentinan and Neoplasm Metastasis
Article | Year |
---|---|
Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Immunotherapy; Lentinan; Neoplasm Metastasis; Neoplasms, Experimental; Polysaccharides | 1987 |
1 trial(s) available for lentinan and Neoplasm Metastasis
Article | Year |
---|---|
[Effect of lentinan for advanced prostate carcinoma].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Injections, Intramuscular; Lentinan; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Prostatic Neoplasms; Survival Rate; Tegafur | 1994 |
5 other study(ies) available for lentinan and Neoplasm Metastasis
Article | Year |
---|---|
Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Epithelial-Mesenchymal Transition; HEK293 Cells; Humans; Lentinan; MCF-7 Cells; Melanoma, Experimental; Mice; Neoplasm Metastasis; NIH 3T3 Cells; Polysaccharides; Selenium; Xenograft Model Antitumor Assays | 2018 |
Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatments.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fibrosarcoma; Hypersensitivity, Delayed; Immunologic Memory; Immunotherapy; Interleukin-2; Killer Cells, Natural; Lentinan; Lung Neoplasms; Melanoma, Experimental; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Postoperative Care; Preoperative Care | 1994 |
Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.
Topics: Animals; Cytotoxicity, Immunologic; Humans; Lentinan; Lung Neoplasms; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms | 1993 |
Experimental metastasis inhibition by pretreatment of the host.
Topics: Animals; Epoprostenol; Glycosaminoglycans; Lentinan; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oligopeptides; Peptide Fragments; Polysaccharides; Suramin; Thymopoietins | 1990 |
[Experimental studies on growth inhibition and regression of cancer metastases].
Topics: Animals; Combined Modality Therapy; Fibrosarcoma; Humans; Lentinan; Liver Neoplasms, Experimental; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasms, Experimental; Rats | 1985 |